The National Cancer Institute (NCI) began its Community Clinical Oncology Program (CCOP) in 1983 to link community cancer specialists, primary care physicians and other healthcare professionals to NCI-supported cooperative groups and cancer centers. This enables CCOPs to conduct NCI-approved cancer treatment, prevention and control clinical trials in their respective areas.
A network for testing and validating medical interventions against cancer, the CCOP delivers the benefits of scientific discovery to the public and community physicians. In short, the CCOP makes it possible for state-of-the-art cancer clinical trials to be readily available within communities throughout the country.
The Oklahoma Community Clinical Oncology Program at the Natalie Warren Bryant Cancer Center has maintained its CCOP status since the program began. This distinction allows the center to provide area patients access to nationwide clinical trials.